NCT01316770 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Izumi M, Eguchi K, Nakamura H, Takagi Y, Kawabe Y, Nakamura T
Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome. Ann Rheum Dis. 1998 Aug;57(8):464-9.
Manor W
A clinical learning experience in discharge planning. Nurse Educ. 1991 Nov-Dec;16(6):35.
Takagi Y, Katayama I, Tashiro S, Nakamura T
Parotid irrigation and cevimeline gargle for treatment of xerostomia in Sjögren's syndrome. J Rheumatol. 2008 Nov;35(11):2289-91. doi: 10.3899/jrheum.080370.

A Randomized Within-Subject, Double-Blind, Placebo-Controlled Study of Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects

Details for clinical trial NCT01316770

Clinical trial NCT01316770 - References